Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

被引:48
|
作者
Bicknell, Brian [1 ]
Liebert, Ann [1 ,2 ,3 ]
Borody, Thomas [4 ]
Herkes, Geoffrey [3 ]
McLachlan, Craig [5 ]
Kiat, Hosen [1 ,5 ,6 ,7 ]
机构
[1] Univ Western Sydney, NICM Hlth Res Inst, Westmead, NSW 2145, Australia
[2] Univ Sydney, Fac Med & Hlth, Camperdown, NSW 2006, Australia
[3] Sydney Adventist Hosp, Dept Governance & Res, Wahroonga, NSW 2076, Australia
[4] Ctr Digest Dis, Five Dock, NSW 2046, Australia
[5] Torrens Univ Australia, Ctr Hlth Futures, Ultimo, NSW 2007, Australia
[6] Macquarie Univ, Macquarie Med Sch, Macquarie Pk, NSW 2109, Australia
[7] Australian Natl Univ, ANU Coll Hlth & Med, Canberra, ACT 2601, Australia
关键词
microbiome; photobiomodulation; faecal microbiome transplants; neurodegenerative disease; neurodevelopmental disease; Alzheimer's disease; Parkinson's disease; autism spectrum disorder; NEAR-INFRARED LIGHT; PROTON PUMP INHIBITORS; CHAIN FATTY-ACIDS; PARKINSONS-DISEASE; INTESTINAL MICROBIOTA; PHOTOBIOMODULATION THERAPY; NEUROPSYCHIATRIC DISORDERS; INSULIN SENSITIVITY; ULCERATIVE-COLITIS; MULTIPLE-SCLEROSIS;
D O I
10.3390/ijms24119577
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human gut microbiome contains the largest number of bacteria in the body and has the potential to greatly influence metabolism, not only locally but also systemically. There is an established link between a healthy, balanced, and diverse microbiome and overall health. When the gut microbiome becomes unbalanced (dysbiosis) through dietary changes, medication use, lifestyle choices, environmental factors, and ageing, this has a profound effect on our health and is linked to many diseases, including lifestyle diseases, metabolic diseases, inflammatory diseases, and neurological diseases. While this link in humans is largely an association of dysbiosis with disease, in animal models, a causative link can be demonstrated. The link between the gut and the brain is particularly important in maintaining brain health, with a strong association between dysbiosis in the gut and neurodegenerative and neurodevelopmental diseases. This link suggests not only that the gut microbiota composition can be used to make an early diagnosis of neurodegenerative and neurodevelopmental diseases but also that modifying the gut microbiome to influence the microbiome-gut-brain axis might present a therapeutic target for diseases that have proved intractable, with the aim of altering the trajectory of neurodegenerative and neurodevelopmental diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, autism spectrum disorder, and attention-deficit hyperactivity disorder, among others. There is also a microbiome-gut-brain link to other potentially reversible neurological diseases, such as migraine, post-operative cognitive dysfunction, and long COVID, which might be considered models of therapy for neurodegenerative disease. The role of traditional methods in altering the microbiome, as well as newer, more novel treatments such as faecal microbiome transplants and photobiomodulation, are discussed.
引用
收藏
页数:50
相关论文
共 50 条
  • [1] Neurodegenerative diseases: from gut-brain axis to brain microbiome
    Friedland, Robert P.
    Haribabu, Bodduluri
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [2] Editorial: Neurodegenerative diseases: From gut-brain axis to brain microbiome
    Tetz, George
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [3] The gut microbiome and pharmacology: a prescription for therapeutic targeting of the gut-brain axis
    Leprun, Pauline M. B.
    Clarke, Gerard
    CURRENT OPINION IN PHARMACOLOGY, 2019, 49 : 17 - 23
  • [4] Traumatic Brain Injury and Gut Microbiome: The Role of the Gut-Brain Axis in Neurodegenerative Processes
    Lin, Derek
    Howard, Andrea
    Raihane, Ahmed S.
    Di Napoli, Mario
    Caceres, Eder
    Ortiz, Michael
    Davis, Justin
    Abdelrahman, Allae N.
    Divani, Afshin A.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2025, 25 (01)
  • [5] Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
    Toledo, Alma Rosa Lezama
    Monroy, German Rivera
    Salazar, Felipe Esparza
    Lee, Jea-Young
    Jain, Shalini
    Yadav, Hariom
    Borlongan, Cesario Venturina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [6] Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases
    Cheng, Yufeng
    Chen, Ce
    Zhang, Feng
    AGEING RESEARCH REVIEWS, 2023, 85
  • [7] Neonatal Microbiome and the Gut-Brain Axis: Is It the Origin of Adult Diseases?
    Soliman, Yssra S.
    Elkhateb, Islam T.
    Aly, Hany Z.
    JOURNAL OF PEDIATRIC NEUROLOGY, 2019, 17 (03) : 95 - 104
  • [8] Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases
    Sivamaruthi, Bhagavathi Sundaram
    Suganthy, Natarajan
    Pellegrini, Carolina
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases
    Munir, Muhammad Usman
    Ali, Syed Aoun
    Chung, Ka Hang Karen
    Kakinen, Aleksandr
    Javed, Ibrahim
    Davis, Thomas Paul
    GUT MICROBES, 2024, 16 (01)
  • [10] Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
    Westfall, Susan
    Lomis, Nikita
    Kahouli, Imen
    Dia, Si Yuan
    Singh, Surya Pratap
    Prakash, Satya
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (20) : 3769 - 3787